Avery Schumer
All posts from Avery Schumer
Avery Schumer in Insider trading,

Chardan: Time To Buy The Medicines Co.

The Medicines Company  reported its third-quarter results, beating estimates on the earnings front but missing on the revenue front.

Following the earnings call, Chardan analyst Gbola Amusa initiated coverage on the stock with a Buy rating and $50 price target.